Cargando…

Cardiovascular outcomes of metformin use in patients with type 2 diabetes and chronic obstructive pulmonary disease

Aim: To know whether metformin use has different influence on cardiovascular risks in patients with type 2 diabetes mellitus (T2DM) and chronic obstructive pulmonary disease (COPD) as compared with metformin no-use. Methods: This study employed a retrospective cohort study design. Using propensity s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yen, Fu-Shun, Wei, James Cheng-Chung, Chiu, Lu-Ting, Hsu, Chih-Cheng, Hwu, Chii-Min
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9441545/ https://www.ncbi.nlm.nih.gov/pubmed/36071848 http://dx.doi.org/10.3389/fphar.2022.919881

Ejemplares similares

Respiratory outcomes of metformin use in patients with type 2 diabetes and chronic obstructive pulmonary disease
por: Yen, Fu-Shun, et al.
Publicado: (2020)

Effects of metformin use on total mortality in patients with type 2 diabetes and chronic obstructive pulmonary disease: A matched-subject design
por: Yen, Fu-Shun, et al.
Publicado: (2018)

Thiazolidinedione Use in Individuals With Type 2 Diabetes and Chronic Obstructive Pulmonary Disease
por: Yen, Fu-Shun, et al.
Publicado: (2021)

Diabetes, hypertension, and cardiovascular disease development
por: Yen, Fu-Shun, et al.
Publicado: (2022)

Metformin and the Risk of Chronic Urticaria in Patients with Type 2 Diabetes
por: Yen, Fu-Shun, et al.
Publicado: (2022)

Liver-related long-term outcomes of alpha-glucosidase inhibitors in patients with diabetes and liver cirrhosis
por: Yen, Fu-Shun, et al.
Publicado: (2022)

Metformin use and the risk of bacterial pneumonia in patients with type 2 diabetes
por: Yen, Fu-Shun, et al.
Publicado: (2022)

Metformin and the Development of Asthma in Patients with Type 2 Diabetes
por: Yen, Fu-Shun, et al.
Publicado: (2022)

Impacts of early insulin treatment vs glimepiride in diabetic patients with background metformin therapy: A nationwide retrospective cohort study
por: Yen, Fu-Shun, et al.
Publicado: (2021)

Role of Metformin in Morbidity and Mortality Associated with Urinary Tract Infections in Patients with Type 2 Diabetes
por: Yen, Fu-Shun, et al.
Publicado: (2022)

Metformin Use before Influenza Vaccination May Lower the Risks of Influenza and Related Complications
por: Yen, Fu-Shun, et al.
Publicado: (2022)

Metformin use and cirrhotic decompensation in patients with type 2 diabetes and liver cirrhosis
por: Yen, Fu‐Shun, et al.
Publicado: (2021)

Sulfonylureas may be useful for glycemic management in patients with diabetes and liver cirrhosis
por: Yen, Fu-Shun, et al.
Publicado: (2020)

Is insulin the preferred treatment in persons with type 2 diabetes and liver cirrhosis?
por: Yen, Fu-Shun, et al.
Publicado: (2021)

Selection and Warning of Evidence-Based Antidiabetic Medications for Patients With Chronic Liver Disease
por: Yen, Fu-Shun, et al.
Publicado: (2022)

Sulfonylurea Use in Patients with Type 2 Diabetes and COPD: A Nationwide Population-Based Cohort Study
por: Yen, Fu-Shun, et al.
Publicado: (2022)

Parental Income Level and Risk of Developing Type 2 Diabetes in Youth
por: Yen, Fu-Shun, et al.
Publicado: (2023)

Clinical course of adolescents with type 2 diabetes mellitus: A nationwide cohort study in Taiwan
por: Yen, Fu‐Shun, et al.
Publicado: (2022)

Thiazolidinediones lower the risk of pneumonia in patients with type 2 diabetes
por: Yen, Fu-Shun, et al.
Publicado: (2023)

Long-term outcomes of adding alpha-glucosidase inhibitors in insulin-treated patients with type 2 diabetes
por: Yen, Fu-Shun, et al.
Publicado: (2021)

The Risk of Nephropathy, Retinopathy, and Leg Amputation in Patients With Diabetes and Hypertension: A Nationwide, Population-Based Retrospective Cohort Study
por: Yen, Fu-Shun, et al.
Publicado: (2021)

Impact of individual microvascular disease on the risks of macrovascular complications in type 2 diabetes: a nationwide population-based cohort study
por: Yen, Fu-Shun, et al.
Publicado: (2023)

Persons with type 2 diabetes and high insulin persistence were associated with a lower risk of mortality: A nationwide retrospective cohort study
por: Yen, Fu‐Shun, et al.
Publicado: (2020)

Severe hypoglycemia in patients with liver cirrhosis and type 2 diabetes
por: Yen, Fu-Shun, et al.
Publicado: (2023)

Urate-lowering Therapy and Chronic Kidney Disease Development in Patients with Gout
por: Yen, Fu-Shun, et al.
Publicado: (2021)

Urate-lowering therapy may mitigate the risks of hospitalized stroke and mortality in patients with gout
por: Yen, Fu-Shun, et al.
Publicado: (2020)

Urate-Lowering Therapy May Prevent the Development of Coronary Artery Disease in Patients With Gout
por: Yen, Fu-Shun, et al.
Publicado: (2020)

All-cause mortality of insulin plus dipeptidyl peptidase-4 inhibitors in persons with type 2 diabetes
por: Yen, Fu-Shun, et al.
Publicado: (2019)

Challenges of optimizing insulin therapy for patients with type 2 diabetes mellitus
por: Yen, Fu‐Shun, et al.
Publicado: (2021)

Similarities and differences in the natural history of youth‐onset type 2 diabetes between the West and Asia
por: Yen, Fu‐Shun, et al.
Publicado: (2022)

Statins for the Treatment of Pulmonary Hypertension in Patients with Chronic Obstructive Pulmonary Disease
por: Chen, Chung-Yu, et al.
Publicado: (2021)

Liver‐related long‐term outcomes of thiazolidinedione use in persons with type 2 diabetes
por: Yen, Fu‐Shun, et al.
Publicado: (2020)

Diet and exercise are a fundamental part of comprehensive care for type 2 diabetes
por: Yeh, Yun Kai, et al.
Publicado: (2023)

Statin use and Vital Organ Failure in Patients With Asthma–Chronic Obstructive Pulmonary Disease Overlap: A Time-Dependent Population-Based Study
por: Yeh, Jun-Jun, et al.
Publicado: (2019)

Imbalance of Endogenous Hydrogen Sulfide and Homocysteine in Chronic Obstructive Pulmonary Disease Combined with Cardiovascular Disease
por: He, Yanjing, et al.
Publicado: (2017)

Is a low‐carbohydrate, high‐fat diet feasible for people with type 2 diabetes and nonalcoholic fatty liver disease?
por: Yen, Fu‐Shun, et al.
Publicado: (2023)

Risk for Cardiovascular Disease and One-Year Mortality in Patients With Chronic Obstructive Pulmonary Disease and Obstructive Sleep Apnea Syndrome Overlap Syndrome
por: Tang, Manyun, et al.
Publicado: (2021)

Drug Safety of Benzodiazepines in Asian Patients With Chronic Obstructive Pulmonary Disease
por: Liao, Yi-Hsiang, et al.
Publicado: (2020)

Role of Proteases in Chronic Obstructive Pulmonary Disease
por: Pandey, Kailash C., et al.
Publicado: (2017)

Blood Cadmium Levels and Oxygen Desaturation during the 6-Minute Walk Test in Patients with Chronic Obstructive Pulmonary Disease
por: Chiu, Li-Chung, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ofg8avaadot3r4e9gfm0imcn2p